Cano Health ROE 2020-2024 | CANOQ
Current and historical return on equity (ROE) values for Cano Health (CANOQ) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Cano Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-03-31 | $-0.98B | $-1.01B | 250.67% |
| 2023-12-31 | $-0.59B | $-0.54B | 4400.00% |
| 2023-09-30 | $-0.58B | $-0.26B | -236.72% |
| 2023-06-30 | $-0.37B | $0.24B | -73.57% |
| 2023-03-31 | $-0.24B | $0.50B | -35.85% |
| 2022-12-31 | $-0.21B | $0.49B | -27.88% |
| 2022-09-30 | $-0.04B | $0.78B | -5.03% |
| 2022-06-30 | $-0.01B | $0.84B | -1.20% |
| 2022-03-31 | $0.00B | $0.84B | 0.00% |
| 2021-12-31 | $-0.02B | $0.80B | -2.67% |
| 2021-09-30 | $-0.08B | $0.86B | -18.43% |
| 2021-06-30 | $-0.07B | $0.89B | -29.96% |
| 2021-03-31 | $-0.09B | $0.01B | -535.38% |
| 2020-12-31 | $-0.07B | $0.05B | -473.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.001B | $3.138B |
| Cano Health Inc. is a value-based primary care provider for seniors and underserved communities. It provides health management programs including telehealth, prescription home delivery, wellness programs, transition of care and high-risk and complex care management. Cano Health Inc., formerly known as Jaws Acquisition Corp., is based in MIAMI. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $127.732B | 15.57 |
| Cencora (COR) | United States | $47.268B | 18.06 |
| ICON (ICLR) | Ireland | $24.749B | 22.24 |
| DiDi Global (DIDIY) | China | $18.956B | 0.00 |
| Avantor (AVTR) | United States | $18.274B | 27.71 |
| Natera (NTRA) | United States | $15.647B | 0.00 |
| Revvity (RVTY) | United States | $15.051B | 26.36 |
| Viatris (VTRS) | United States | $13.916B | 4.24 |
| CochLear (CHEOY) | Australia | $12.791B | 0.00 |
| Solventum (SOLV) | United States | $12.090B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.902B | 33.08 |
| Charles River Laboratories (CRL) | United States | $10.254B | 19.38 |
| Sonic Healthcare (SKHHY) | Australia | $8.738B | 0.00 |
| Doximity (DOCS) | United States | $7.300B | 46.26 |
| HealthEquity (HQY) | United States | $6.831B | 37.08 |
| PACS (PACS) | United States | $6.206B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.474B | 23.56 |
| Organon (OGN) | United States | $5.270B | 5.36 |
| Life Times (LTH) | United States | $4.983B | 41.65 |
| Sotera Health (SHC) | United States | $4.758B | 24.00 |
| Surgery Partners (SGRY) | United States | $3.941B | 43.66 |
| GoodRx Holdings (GDRX) | United States | $2.941B | 110.71 |
| Concentras Parent (CON) | United States | $2.927B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.591B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $2.375B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.275B | 0.00 |
| Progyny (PGNY) | United States | $2.180B | 38.33 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.064B | 0.00 |
| Premier (PINC) | United States | $2.033B | 9.14 |
| AMN Healthcare Services Inc (AMN) | United States | $1.791B | 9.00 |
| CareDx (CDNA) | United States | $1.523B | 0.00 |
| Agilon Health (AGL) | United States | $1.453B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.385B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.235B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.020B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.939B | 10.21 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Embecta (EMBC) | United States | $0.924B | 6.16 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.540B | 0.00 |
| Sharecare (SHCR) | United States | $0.519B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.496B | 0.00 |
| Enhabit (EHAB) | United States | $0.407B | 35.22 |
| Sonida Senior Living (SNDA) | United States | $0.379B | 0.00 |
| DocGo (DCGO) | United States | $0.373B | 14.04 |
| Biodesix (BDSX) | United States | $0.257B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.256B | 0.00 |
| LifeMD (LFMD) | United States | $0.227B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.208B | 0.00 |
| ModivCare (MODV) | United States | $0.201B | 6.39 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| MultiPlan (MPLN) | United States | $0.148B | 0.00 |
| Nutex Health (NUTX) | United States | $0.128B | 0.00 |
| So-Young (SY) | China | $0.087B | 21.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.081B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.058B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 1.74 |
| Co-Diagnostics (CODX) | United States | $0.042B | 0.00 |
| OncoCyte (OCX) | United States | $0.041B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.025B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |